CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 03/31/2024 | 03/31/2023 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -5.10M | -6.56M | -- |
| Total Depreciation and Amortization | -- | -- | 11.60K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | 1.70K | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -- | -- | -167.60K | -141.60K | -- |
| Cash from Operations | -- | -- | -5.25M | -6.70M | -- |
| Capital Expenditure | -- | -- | -186.10K | -219.40K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -34.40K | -43.30K | -- |
| Cash from Investing | -- | -- | -220.20K | -262.40K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 5.92M | 8.00M | -- |
| Repurchase of Common Stock | -- | -- | -260.90K | -260.90K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 5.66M | 7.74M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 190.80K | 782.50K | -- |
